Mystie DaRocha Email

Senior Director, Finance . Anokion

Current Roles

Employees:
39
Revenue:
$3M
About
Anokion, a spin-off from the Ecole Polytechnique Fédérale de Lausanne (EPFL), is focused on applying the company?s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion?s approach to antigen-specific tolerance can be translated to virtually any protein in numerous clinical indications. www.anokion.com
Anokion Address
50 Hampshire Street
Cambridge, MA
United States
Anokion Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.